Anna Russo
Vice President, Machine Learning and Artificial Intelligence
8 May, 2025
Led by industry expert Anna Russo, this session highlights how AI-driven technologies—from natural language processing to predictive analytics—can reduce manual burdens, improve risk detection, and support regulatory compliance in pharmacovigilance. You’ll gain practical insights into integrating AI to optimize safety monitoring and streamline decision-making across development stages.
Vice President, Machine Learning and Artificial Intelligence
This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.